Z

Zenas Biopharma Inc.
D

ZBIO

40.440
USD
0.57
(1.43%)
مغلق
حجم التداول
0
الربح لكل سهم
-4
العائد الربحي
-
P/E
-3
حجم السوق
2,170,785,473
المقالات

العنوان: Zenas Biopharma Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.